The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience

Figure 1

Cumulative probability of maintaining MMR on imatinib assessed by Hasford risk score (LR, low-risk group, IR, intermediate-risk group).